ArticleSurgical endoscopy2021
Robotic Complete Mesocolic Excision (CME) is a safe and feasible option for right colonic cancers: short and midterm results from a single-centre experience.
Article in Surgical endoscopy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Learning curve of minimally invasive complete mesocolic excision for right-sided colon cancer: a systematic review.Surgical endoscopy · 2025Pooled it
- Training and assessment for colorectal surgery and appendicectomy- a systematic review.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2024Pooled it
- Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review.Surgical endoscopy · 2023Pooled it
- Learning curves and outcomes of robotic colorectal surgery: A single-surgeon experience within a structured dual-console training program.Journal of robotic surgery · 2026Article
- Concurrent robotic colorectal surgical oncology training within a structured mentored international fellowship program.Journal of robotic surgery · 2025Article
- Oncological surgical outcomes for colorectal cancer surgery with loco-regional anesthesia: A feasibility study.Saudi medical journal · 2025Article
- Robotic right colectomy with complete mesocolic excision, central vascular ligation and hand-sewn intracorporeal anastomosis: feasibility, safety, and learning curve analysis.Frontiers in surgery · 2025Article
- Developing a phantom for simulating robotic-assisted complete mesocolic excision using 3D printing and medical imaging.BMC surgery · 2024Article
- The rise of robotic colorectal surgery: better for patients and better for surgeons.Journal of robotic surgery · 2024Article
- Safe implementation of robotic right colectomy with intracorporeal anastomosis.Journal of robotic surgery · 2023Article
- Robotic complete mesocolic excision of right-sided colon cancer with bulky lymph node metastases using the da VinciOncology letters · 2022Article
- Robotic-assisted Surgery: Expanding Indication to Colon Cancer in Japan.Journal of the anus, rectum and colon · 2022Review
- Updates on Robotic CME for Right Colon Cancer: A Qualitative Systematic Review.Journal of personalized medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplete mesocolic excision (CME) for right colon cancers has traditionally been an open procedure. Surgical adoption of minimal access CME remains limited due to the technical challenges, training gaps and lack of level-1 data for proven benefits. Currently there is limited published data regarding the clinical results with the use of robotic CME surgery. Aim To report our experience, results and techniques, highlighting a clinical and oncological results and midterm oncological outcomes for robotic CME.
aimTo report our experience, results and techniques, highlighting a clinical and oncological results and midterm oncological outcomes for robotic CME.
methodsAll patients undergoing standardised robotic CME technique with SMV first approach between January 2015 and September 2019 were included in this retrospective review of a prospectively collected database. Patient demographics, operative data and clinical and oncological outcomes were recorded.
resultsSeventy-seven robotic CME resections for right colonic cancers were performed over a 4-year period. Median operative time was 180 (128-454) min and perioperative blood loss was 10 (10-50) ml. There were 25 patients who had previous abdominal surgery. Median postoperative hospital stay was 5 (3-18) days. There was no conversion to open surgery in this series. Median lymph node count was 30 (10-60). Three (4%) patients had R1 resection. There was one (1%) local recurrence in stage III disease and 4(5%) distal recurrence in stage II and stage III. There was no 30- or 90-day mortality. Three-year disease-free survival was 100%, 91.7% and 92% for stages I, II and III, respectively. Overall survival was 94%.
conclusionsRobotic CME is feasible, effective and safe. Good oncological results and improved survival are seen in this cohort of patients with a standardised approach to robotic CME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.